At a glance
ClinicalIndex Comparison RecordN/ACompleted· 400 target
Drug / intervention
specific treatment +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Randomized, Controlled, Two-arm Study to Evaluate the Interest of the Pre-conceptional Endometrial Immune Profiling to Increase Birth Rates Through a Care Personalization in Reproductive Medicine Before IVF
In Brief
A clinical study evaluating standard care and specific treatment for Reproductive Medicine. Completed, enrolled 400 participants across 1 site.
Detailed Summary
A prospective, randomized, controlled, open two-arm study to evaluate the interest of the pre-conceptional endometrial immune profiling to increase birth rates.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsReproductive Medicine
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 2014
Enrollment StartOct 2015
Primary CompletionMar 2024
Study CompletionApr 2024
TodayJul 2026
First PostedOct 10, 2014
Enrollment StartOct 30, 2015
Primary CompletionMar 22, 2024
Study CompletionApr 1, 2024
TodayJul 2, 2026
Enrollment to primary: 8.4 yearsPosted 11.7 years ago
Interventions
standard careother
No specific medical care
specific treatmentdrug
Regarding the immune endometrial profiling, medical care (personalization of treatment) should follow a step by step decision tree.